Headline News about Johnson & Johnson
The Analyst Verdict: Johnson & Johnson In The Eyes Of 12 Experts
January 24, 2024
Via Benzinga
Johnson & Johnson To Pay $149M In Opioid Settlement, Washington State AG Says 'We Are Not Done'
January 29, 2024
Via Benzinga
Topics
Lawsuit
Should You Buy the Dogs of the Dow in 2024?
January 27, 2024
Via The Motley Fool
Topics
Stocks
Exposures
US Equities
What's Going On Johnson & Johnson Stock Today?
January 24, 2024
Via Benzinga
Topics
Earnings
Exposures
Financial
Nasdaq, S&P 500 Futures Jump As Wall Street Eagerly Awaits Tesla's Q4 Earnings: Analyst Says Rally Broadening But Favors These Stocks
January 24, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Investor Optimism Improves Following Earnings Reports; S&P 500 Reaches Another High
January 24, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
3 Stocks To Consider After Beating Earnings Estimates
January 23, 2024
Via Talk Markets
Johnson & Johnson (JNJ) Q4 2023 Earnings Call Transcript
January 23, 2024
Via The Motley Fool
Topics
Earnings
Exposures
Financial
US Stocks Pause As Treasury Yields, Dollar Surge On Trimmed Fed Rate Cut Bets: What's Driving Markets Tuesday?
January 23, 2024
Via Benzinga
Topics
Economy
Exposures
Interest Rates
10 Health Care Stocks With Whale Alerts In Today's Session
January 23, 2024
Via Benzinga
US Stocks Mixed; Johnson & Johnson Posts Upbeat Earnings
January 23, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.